BioSpace News Archive

Narcan Creator Takes on Synthetic Opioid Overdoses with Experimental Narcan Nasal Spray

The medication (Narcan nasal spray), should it be approved for use, will be squirted into the nasal passages, ensuring absorption into the body and reversing the overdose effects.

July 14, 2021
·
3 min read
·
Alex Keown
Business

Entos Nets $53 Million to Accelerate AI-Driven Therapies

Through its OrbNet platform, Entos has already forged various partnerships with investors and leaders in the pharmaceuticals, materials, and chemicals industries.

July 14, 2021
·
2 min read
·
Vanessa Doctor, RN
Policy

Bid to Wrest Phoenixus Away from Jailed ‘Pharma Bro’ Fails

Kevin Mulleady and Jason Aryeh attempted to back a slate of candidates for the Phoenixus Board of Directors but failed as shareholders overwhelmingly supported the current board.

July 14, 2021
·
2 min read
·
Alex Keown
Deals

Lilly Spends $1 Billion-Plus on Insulin Innovator Protomer

No specific financial details were disclosed other than to say the $1 billion figure was linked to various development and commercial milestones.

July 14, 2021
·
3 min read
·
Mark Terry
Business

To Achieve What’s Possible, New Freenome CEO Mike Nolan ‘Makes His Own Weather’

The new CEO of Freenome has a talent for “making his own weather.” That’s a phrase he heard often growing up in Rapid City, South Dakota and, when applied to his life and career, comes down to assessing himself accurately and looking for opportunities to contribute.

July 14, 2021
·
5 min read
·
Gail Dutton
Business

Kriya Raises $100 M Series B For AAV-Based Gene Therapies

Kriya Therapeutics, based in Redwood City, Calif. and Research Triangle Park, NC, closed on a Series B financing worth $100 million.

July 14, 2021
·
2 min read
·
Mark Terry
Business

Ribon Therapeutics Snags $65 Million to Advance Lead Candidates

In an interview with BioSpace, CEO Victoria Richon expressed her excitement about investor support and developing novel, first-in-class treatments.

July 14, 2021
·
2 min read
·
Alex Keown
Business

Thermo Fisher and UC Davis Establish Center to Advance Study of Metabolomics

Thermo Fisher Scientific has launched a new collaborative unit that aims to standardize the metabolomics community’s efforts as it engages in more large-scale cohort studies and clinical research.

July 14, 2021
·
2 min read
·
Vanessa Doctor, RN
Global Roundup: Amniotics Snags $6.95 Million to Advance PulmoStem

Biopharma and life sciences companies from across the globe provide updates on their business practices and pipelines.

July 14, 2021
·
5 min read
·
Alex Keown
Biotech Bay

Money on the Move: July 7 – 13

More biopharma companies race toward the Nasdaq this week, while a few rake in cash via private funding rounds.

July 14, 2021
·
4 min read
·
Kate Goodwin